Document Detail

Antifibrinolytic drugs for acute traumatic injury.
MedLine Citation:
PMID:  15495129     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Uncontrolled bleeding is an important cause of death in trauma victims. Antifibrinolytic treatment has been shown to reduce blood loss following surgery and may also be effective in reducing blood loss following trauma.
OBJECTIVES: To quantify the effect of antifibrinolytic drugs in reducing blood loss, transfusion requirement and mortality after acute traumatic injury.
SEARCH STRATEGY: We searched the Cochrane Injuries Group's Specialised Register, the Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, EMBASE, Science Citation Index, National Research Register, Zetoc, SIGLE, Global Health, LILACS, and Current Controlled Trials.
SELECTION CRITERIA: We included all randomised controlled trials of antifibrinolytic agents (aprotinin, tranexamic acid [TXA] and epsilon-aminocaproic acid) following acute traumatic injury.
DATA COLLECTION AND ANALYSIS: The titles and abstracts identified in the electronic searches were screened by two independent reviewers to identify studies that had the potential to meet the inclusion criteria. The full reports of all such studies were obtained. From the results of the screened electronic searches, bibliographic searches, and contacts with experts, two reviewers independently selected trials meeting the inclusion criteria, with any disagreements resolved by consensus.
MAIN RESULTS: Two studies met the inclusion criteria. The study by Auer (1979), with 20 randomised patients, provided no useable outcome data. The study by McMichan (1982), with 77 randomised patients, was reported in four separate reports. Outcome data were reported for death, the proportion undergoing surgical intervention and the volume of blood transfused. Because of the small number of randomised participants, the estimates for each of these outcomes were highly imprecise. Data on the proportion undergoing re-operation and the proportion receiving blood transfusion were not reported.
REVIEWERS' CONCLUSIONS: There is insufficient evidence from randomised controlled trials of antifibrinolytic agents in trauma to either support or refute a clinically important treatment effect. Further randomised controlled trials of antifibrinolytic agents in trauma are required.
T Coats; I Roberts; H Shakur
Related Documents :
9565739 - Safety review of adult clinical trial experience with lamotrigine.
11256729 - History and evidence-based medicine: lessons from the history of somatic treatments fro...
20074149 - Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of ra...
15494999 - Anaesthesia for hip fracture surgery in adults.
11840709 - A complication conference for internal quality control at the neurosurgical department ...
15106239 - Hyperbaric oxygen therapy for chronic wounds.
24954529 - Relapse of skeletal class iii with anterior open bite after bimaxillary orthognathic su...
22481099 - Impact of early intravenous epinephrine administration on outcomes following out-of-hos...
1994659 - The dutch experience in percutaneous transluminal angioplasty of narrowed saphenous vei...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2004-10-18
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2004  
Date Detail:
Created Date:  2004-10-20     Completed Date:  2005-03-23     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD004896     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifibrinolytic Agents / therapeutic use*
Blood Loss, Surgical / prevention & control
Blood Transfusion / utilization*
Hemorrhage / drug therapy*,  etiology
Randomized Controlled Trials as Topic
Wounds and Injuries / complications*
Reg. No./Substance:
0/Antifibrinolytic Agents
Update In:
Cochrane Database Syst Rev. 2011;(1):CD004896   [PMID:  21249666 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fertility awareness-based methods for contraception.
Next Document:  Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.